Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

RTW Investments LLC

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 93
Average round size
info
The average size of a deal this fund participated in
$121M
Portfolio companies 71
Rounds per year 6.64
Lead investments 14
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.24
Exits 31
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Therapeutics
  • Pharmaceutical
  • Medical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of RTW Investments LLC:
Typical Co-investors
RTW Investments LLC is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after RTW Investments LLC:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
9Unicorns Accelerator Fund India, Maharashtra, Mumbai
Cambridge Technology Partners Nyon, Switzerland, Vaud
Chengdu Culture & Tourism Development Group Chengdu, China, Sichuan
Climate Fund Managers -
Exceed Capital Partners California, San Francisco, United States
IC Global Partners Dubai, United Arab Emirates
JM Molina Investments -
Lotus Lake Ventures Beijing, Beijing, China
National Nuclear Security Administration District of Columbia, United States, Washington
National Talents Al Khobar, Ash Sharqiyah, Saudi Arabia
Nomura Asset Management Japan, Tokyo
NovAtel Alberta, Calgary, Canada
One97 Mobility Fund India, Noida, Uttar Pradesh
Prometheus Group North Carolina, Raleigh, United States
Ruyi Capital China, Shanghai
Scentan Ventures Central, Central Region, Singapore
Siena Capital -
Taiyo Kagaku -
Watsco Ventures Florida, Miami, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Obsidian Therapeutics

Biotechnology
Health Care
Pharmaceutical
$160M03 Apr 2024 Cambridge, Massachusetts, United States

Mirador Therapeutics

$400M21 Mar 2024 San Diego, California, United States

Basking Biosciences

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$55M30 Jan 2024 Durham, North Carolina, United States

Kyverna Therapeutics

Biotechnology
Life Science
Therapeutics
$60M03 Aug 2023 Berkeley, California, United States

Abdera Therapeutics

Biotechnology
Health Care
Health Diagnostics
Life Science
$142M20 Apr 2023 Vancouver, British Columbia, Canada

CARGO Therapeutics

Biotechnology
Medical
Therapeutics
$200M01 Mar 2023 Palo Alto, California, United States

Oricell Therapeutics

Health Care
Pharmaceutical
Product Research
$45M28 Feb 2023 Shanghai, Shanghai, China

Apogee Therapeutics

Biotechnology
Life Science
Medical
Therapeutics
$149M07 Dec 2022 San Francisco, California, United States

Mineralys Therapeutics

Biopharma
Biotechnology
Medical
Pharmaceutical
$118M08 Jun 2022 Radnor, Pennsylvania, United States
News
Neurogastrx Secures $60 Million in Series B Financing and Expands Management Team to Advance Its Pipeline of Transformative Investigational Therapies for Gastrointestinal Disorders

– Neurogastrx, a privately held specialty pharmaceutical company developing transformative therapies for gastrointestinal (GI) disorders, announced the successful completion of a $60m Series B crossover round led by Vivo Capital.
– Other new investors participating in the Series B round include RTW Investments, Samsara BioCapital and Marshall Wace, joining 5AM Ventures, venBio and OrbiMed Advisors.
– Proceeds from the financing will be used to advance the company’s pipeline of GI therapies for serious conditions that impact millions of people yet are not effectively treated.

Umoja Biopharma Raises $210M in Series B Funding

– Umoja Biopharma is a Seattle, WA-based oncology company.
– The company closed a $210m Series B financing.
– The round was co-led by SoftBank Vision Fund 2 and Cormorant Asset Management with participation from new investors, including RTW Investments, LP; Temasek; Presight Capital (the international venture arm of Christian Angermayer’s Apeiron Investment Group); Caas Capital; and an investment fund associated with SVB Leerink.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent RTW Investments LLC?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 93
Average round size 121M
Rounds per year 6.64
Peak activity year 2021
Lead investments 14
Follow on index 0.24
Exits 31
Group Appearance index 0.95

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Obsidian Therapeutics

Biotechnology
Health Care
Pharmaceutical
$160M03 Apr 2024 Cambridge, Massachusetts, United States

Mirador Therapeutics

$400M21 Mar 2024 San Diego, California, United States

Basking Biosciences

Biotechnology
Health Care
Pharmaceutical
Therapeutics
$55M30 Jan 2024 Durham, North Carolina, United States

Kyverna Therapeutics

Biotechnology
Life Science
Therapeutics
$60M03 Aug 2023 Berkeley, California, United States

Abdera Therapeutics

Biotechnology
Health Care
Health Diagnostics
Life Science
$142M20 Apr 2023 Vancouver, British Columbia, Canada

CARGO Therapeutics

Biotechnology
Medical
Therapeutics
$200M01 Mar 2023 Palo Alto, California, United States

Oricell Therapeutics

Health Care
Pharmaceutical
Product Research
$45M28 Feb 2023 Shanghai, Shanghai, China

Apogee Therapeutics

Biotechnology
Life Science
Medical
Therapeutics
$149M07 Dec 2022 San Francisco, California, United States

Mineralys Therapeutics

Biopharma
Biotechnology
Medical
Pharmaceutical
$118M08 Jun 2022 Radnor, Pennsylvania, United States
Crunchbase icon

Content report

The following text will be sent to our editors: